Evaluation of Medical Device
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03329768|
Recruitment Status : Recruiting
First Posted : November 6, 2017
Last Update Posted : November 6, 2017
A preliminary study was conducted from 01/26/2015 to 10/26/2015 on 605 patients admitted to MIA with an intravenous and/or a urinary catheter.
the investigators analyzed:
- the demographic characteristics of the patient
- the final diagnosis
- the patient's severity and the patient outcome after discharge from MIA
- the justification of the venous and or a urinary catheter
- the duration of the prescription of the device Evaluation on admission of the need to maintain an intravenous or urinary catheter. Adjusting the prescription in terms of duration or withdrawal of the device in order to limit their complications (lymphangitis, superficial thrombophlebitis, bacteremia related to health care, urinary tract infection).
Limit the length of stay and reduce the cost of hospitalization.
|Condition or disease|
|Acute Infectious Diseases|
|Study Type :||Observational|
|Estimated Enrollment :||2000 participants|
|Official Title:||Evaluation of Peripheral Intravenous Catheter and Urinary Catheters Present on Admission to the "Maladies Infectieuses aiguës" Department.|
|Actual Study Start Date :||September 28, 2016|
|Estimated Primary Completion Date :||September 2019|
|Estimated Study Completion Date :||March 2020|
- number of patients with intravenous catheter [ Time Frame: 3 YEARS ]
- number of patients with urinary catheter [ Time Frame: 3 YEARS ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03329768
|Contact: philippe firstname.lastname@example.org|
|Assistance Publique Hopitaux de Marseille||Recruiting|
|Marseille, France, 13354|
|Contact: PHILIPPE PAROLA email@example.com|
|Principal Investigator: philippe parola|
|Study Director:||jean-olivier ARNAUD||Assistance Publique Hopitaux De Marseille|